Evaluating ICD Guidelines in Adults with Congenital Heart Disease
Author Information
Author(s): Kawada Satoshi MD, PhD, Chakraborty Praloy DM, FACC, Nanthakumar Jared, Albertini Lisa MD, Oechslin Erwin N. MD, Roche Susan Lucy MD, Silversides Candice MD, Wald Rachel M. MD, Downar Eugene MD, Harris Louise MD, Swan Lorna MD, Alonso-Gonzalez Rafael MD, Thorne Sara MD, Nanthakumar Kumaraswamy MD, Mondésert Blandine MD, Khairy Paul MD, PhD, Nair Krishnakumar DM
Primary Institution: University Health Network Toronto, Peter Munk Cardiac Centre, and University of Toronto, Toronto, Ontario, Canada
Hypothesis
The study aims to evaluate the appropriateness of current ICD guidelines in adults with congenital heart disease.
Conclusion
Implantation of ICDs for preventing sudden cardiac death based on current guidelines is reasonable.
Supporting Evidence
- ICD therapy was appropriate in 17.6% of patients during follow-up.
- Patients with Class I indications received more appropriate therapy compared to those with Class IIa and IIb indications.
- Younger age and renal dysfunction were associated with appropriate ICD therapy.
Takeaway
This study looked at how well current guidelines for heart devices work for adults with heart defects, finding that younger patients and those with kidney issues may need special attention.
Methodology
The study reviewed medical records of 131 ACHD patients who underwent ICD implantation from 2010 to 2017.
Potential Biases
The decision regarding device implantation was often left to the physician's discretion before the publication of guidelines.
Limitations
The study is a nonrandomized retrospective analysis from a single center with a small number of participants.
Participant Demographics
Mean age of participants was 42.8 years, with 73.3% being male.
Statistical Information
P-Value
0.030
Confidence Interval
1.045–1.505
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website